Core Viewpoint - A class action lawsuit has been filed against 3D Systems Corporation, alleging that the company made misleading statements regarding its financial health and the impact of customer spending on its business [3][4]. Financial Performance - For Q4 2024, 3D Systems reported a non-GAAP loss of $0.19 per share, missing consensus estimates by $0.08 [6]. - Q4 revenue was $111 million, representing a 3.4% year-over-year decline and falling short of expectations by $4.17 million [6]. - Full-year revenue for 2024 was $440.1 million, a 10% decline year-over-year attributed to lower hardware sales and macroeconomic challenges [6]. - The company experienced a $9 million revenue reduction in Q4 related to revised accounting estimates for its Regenerative Medicine Program [6]. Recent Developments - On March 26, 2025, 3D Systems disclosed its Q4 and full-year 2024 financial results, leading to a nearly 21% decline in its stock price [4]. - On May 12, 2025, the company announced its Q1 2025 results, revealing a revenue of $94.5 million, an 8% year-over-year decline, and a net loss of $37 million, more than double the loss from Q1 2024 [6]. - The company withdrew its full-year 2025 guidance, citing ongoing softness in customer capital spending and broader macroeconomic uncertainty [4][6]. Legal Context - The class action lawsuit represents investors who purchased securities between August 13, 2024, and May 12, 2025, with a deadline of August 12, 2025, to file a lead plaintiff motion [1]. - Allegations include that 3D Systems understated the impact of weakened customer spending and overstated its ability to navigate challenging market conditions [3].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of 3D Systems Corporation regarding a class action lawsuit due to alleged misleading statements and omissions made by the company during a specified class period [1][3]. Group 1: Allegations - The complaint alleges that 3D Systems understated the impact of weakened customer spending on its business while overstating its resilience in challenging industry conditions [3]. - It is also claimed that updated milestone criteria in the partnership with United Therapeutics Corporation would negatively impact the revenue from the company's regenerative medicine program [3]. - As a result, the company's public statements were deemed materially false and misleading throughout the relevant times [3]. Group 2: Class Action Details - The class period for the lawsuit is defined as August 13, 2024, to May 12, 2025 [3]. - Shareholders are encouraged to register for the class action by the deadline of August 12, 2025, to potentially become lead plaintiffs [4]. - Participation in the case does not incur any cost or obligation for shareholders [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered due to deceit, fraud, and illegal business practices [5]. - The firm aims to ensure that companies adhere to responsible business practices and engage in good corporate citizenship [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of 3D Systems Corporation during the specified Class Period of the upcoming lead plaintiff deadline on August 12, 2025, for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought 3D Systems securities between August 13, 2024, and May 12, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by August 12, 2025 [2]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time and being ranked No. 1 for the number of settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [3]. Group 3: Case Allegations - The lawsuit alleges that during the Class Period, 3D Systems made false and misleading statements regarding the impact of weakened customer spending and overstated its resilience in challenging industry conditions [4]. - It is claimed that the updated milestone criteria in a partnership with United Therapeutics Corporation would negatively affect 3D Systems' Regenerative Medicine Program revenue, leading to materially false public statements [4].

Core Viewpoint - Velo3D, Inc. is set to release its second quarter 2025 financial results on August 6, 2025, and will host a conference call to discuss these results [1][2]. Company Overview - Velo3D is a leading US-based metal 3D printing technology company that specializes in additive manufacturing (AM) [4]. - The company has developed solutions that overcome the limitations of legacy metal AM, allowing for the design and production of high-value metal parts [5]. - Velo3D's technology is utilized in various industries, including space exploration, aviation, power generation, energy, and semiconductors, enabling the creation of mission-critical components [5]. Technology and Innovation - The company's integrated solution includes Flow print preparation software, the Sapphire family of printers, and the Assure quality control system, all powered by Velo3D's Intelligent Fusion manufacturing process [5]. - Velo3D has been recognized as one of Fast Company's Most Innovative Companies for 2023, highlighting its impact on the industry [5].

NEW YORK, Aug. 1, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in 3D Systems Corporation ("3D Systems Corporation" or the "Company") (NYSE: DDD) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of 3D Systems Corporation investors who were adversely affected by alleged securities fraud between August 13, 2024 and May 12, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/3d-s ...

Company Overview - SecureTech Innovations, Inc. is a pioneering technology company focused on advancing artificial intelligence, industrial 3D printing, cybersecurity, and digital infrastructure solutions [6] - The company’s portfolio includes AI UltraProd, Piranha Blockchain, and Top Kontrol, which address various real-world challenges [6] Market Position - SecureTech's common stock has been approved for trading on the OTCQB® Venture Market, marking a significant upgrade from the previous OTCID market [1][2] - The OTCQB is recognized by the U.S. Securities and Exchange Commission (SEC) as an established public market, providing enhanced transparency, improved liquidity, and increased visibility for investors [2] Strategic Goals - The uplisting to the OTCQB is viewed as a major milestone and a validation of the company's commitment to transparency and shareholder value [3] - The company aims for a long-term goal of listing on a national exchange such as the NYSE or NASDAQ, which would enhance capital access and strategic partnerships [3]

NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of 3D Systems Corporation (NYSE: DDD) between August 13, 2024 and May 12, 2025, both dates inclusive (the “Class Period”), of the important August 12, 2025 lead plaintiff deadline. SO WHAT: If you purchased 3D Systems securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. ...

NEW YORK, July 31, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of 3D Systems Corporation (NYSE: DDD). WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. T ...

ROCK HILL, S.C., July 29, 2025 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE: DDD) announced full commercial release of its NextDent Jetted Denture Solution for the U.S. market. This first-to-market solution for jetted, monolithic (one-piece) dentures utilizes multiple materials in a single printing process to deliver a durable, long-wear, aesthetically beautiful prosthetic to the patient. This results in a faster, more cost-effective and highly scalable alternative to traditional denture fabrication, enablin ...

Core Viewpoint - A class action lawsuit has been filed against 3D Systems Corporation, alleging that the company made misleading statements regarding its financial health and the impact of customer spending on its business [3][4]. Financial Performance - 3D Systems reported a Q4 non-GAAP loss of $0.19 per share, missing consensus estimates by $0.08 [6] - Q4 revenue was $111 million, representing a 3.4% year-over-year decline and falling short of expectations by $4.17 million [6] - Full-year revenue for 2024 was $440.1 million, a 10% decline year-over-year attributed to lower hardware sales and macroeconomic challenges [6] - The company experienced a $9 million revenue reduction in Q4 due to revised accounting estimates for its Regenerative Medicine Program [6] - In Q1 2025, revenue was $94.5 million, an 8% year-over-year decline, and below the consensus estimate of $99.5 million [6] - The net loss for Q1 2025 was $37 million (or $0.28 per share), more than double the $16 million loss in Q1 2024 [6] - An adjusted loss of $0.21 per share was reported, worse than the expected $0.14 loss [6] - The adjusted EBITDA was negative at $23.9 million, compared to a $20.1 million loss in Q1 2024 [6] Class Action Details - The class action lawsuit covers investors who purchased securities between August 13, 2024, and May 12, 2025 [1] - Investors have until August 12, 2025, to file a lead plaintiff motion [1] - The lawsuit claims that 3D Systems failed to disclose the negative impact of weakened customer spending and changes in its partnership with United Therapeutics Corporation [3]